Adsorptive Cathodic Stripping Voltammetric Determination of Ciprofloxacin in Bulk Powder, Pharmaceutical Dosage Forms and Urine
Purpose: To investigate the electro-reduction behaviour and determination of ciprofloxacin using a hanging mercury drop electrode.
Methods: Cyclic voltammograms of ciprofloxacin recorded in Britton – Robinson buffers pH 2 – 5 exhibit a single irreversible cathodic peak. The dependence of the peak current and peak potential values on buffer (nature, pH and concentration) and accumulation conditions (time and potential) were examined and used for the quantitative analysis of ciprofloxacin in dosage forms and urine. Acetate buffer (0.08 M, pH 3.6) was selected as a supporting electrolyte for quantitative purposes by differential pulse and square wave adsorptive cathodic stripping voltammetry.
Results: A reduction wave was seen in the range of – 1.3 to – 1.5 V. These techniques were successfully validated as per ICH guidelines and comparable to US Pharmacopoeia HPLC method. The techniques was applied to the determination of ciprofloxacin in pharmaceutical formulations (i.e. precision (RSD < 1%) and accuracy (99 – 101%)), and was further extended to determine ciprofloxacin in spiked human urine with no matrix effect (i.e. LLOQ 0.01 μg/ml, precision (RSD < 15%) and accuracy (85 – 115%)).
Conclusion: Validated adsorptive cathodic stripping voltammetric technique can be recommended for use in quality control and pharmacokinetics studies.
Keywords: Ciprofloxacin, Mercury electrode, Adsorptive cathodic stripping voltammetry, Pharmaceutical formulation, Urine.
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.